Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Haufroid

Showing results (101-110 of 160) with videos related to

Pageof 16
Sort By:
Clinical Chemistry and Laboratory Medicine|October 13, 2006
The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal functionMichel Mourad, Pierre Wallemacq, Martine De Meyer, et al.
Pharmacogenomics|April 27, 2010
CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantationArnaud Capron, Michel Mourad, Martine De Meyer, et al.
Transplantation|May 24, 2008
Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcomeMichel Mourad, Pierre Wallemacq, Martine De Meyer, et al.
Pharmacogenomics|June 9, 2016
Pharmacogenetic-based strategy using de novo tacrolimus once daily after kidney transplantation: prospective pilot studyMartine De Meyer, Vincent Haufroid, Nada Kanaan, et al.
Environmental Health : a Global Access Science Source|April 6, 2016
Preeclampsia and toxic metals: a case-control study in Kinshasa, DR CongoJean-Pierre Elongi Moyene, Hans Scheers, Barthélémy Tandu-Umba, et al.
Clinical Chemistry|September 10, 2011
A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipientsLaure Elens, Rachida Bouamar, Dennis A Hesselink, et al.
Archives of Toxicology|March 29, 2021
Systemic effects and impact on the gut microbiota upon subacute oral exposure to silver acetate in ratsDominique Lison, Jérôme Ambroise, Riccardo Leinardi, et al.
Clinical Biochemistry|January 9, 2016
Quantification of darunavir and etravirine in human peripheral blood mononuclear cells using high performance liquid chromatography tandem mass spectrometry (LC-MS/MS), clinical application in a cohort of 110 HIV-1 infected patients and evidence of a potential drug-drug interactionLeïla Belkhir, Morgane De Laveleye, Bernard Vandercam, et al.
Scientific Reports|July 15, 2024
Effect of ABCB1 most frequent polymorphisms on the accumulation of bictegravir in recombinant HEK293 cell linesJulien De Greef, Mathilde Akue, Nadtha Panin, et al.
Pharmacogenetics and Genomics|September 28, 2011
Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in the Rotterdam StudyLaure Elens, Matthijs L Becker, Vincent Haufroid, et al.
Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
Clinical Chemistry and Laboratory Medicine|October 13, 2006
The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal functionMichel Mourad, Pierre Wallemacq, Martine De Meyer, et al.
Pharmacogenomics|April 27, 2010
CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantationArnaud Capron, Michel Mourad, Martine De Meyer, et al.
Transplantation|May 24, 2008
Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcomeMichel Mourad, Pierre Wallemacq, Martine De Meyer, et al.
Pharmacogenomics|June 9, 2016
Pharmacogenetic-based strategy using de novo tacrolimus once daily after kidney transplantation: prospective pilot studyMartine De Meyer, Vincent Haufroid, Nada Kanaan, et al.
Environmental Health : a Global Access Science Source|April 6, 2016
Preeclampsia and toxic metals: a case-control study in Kinshasa, DR CongoJean-Pierre Elongi Moyene, Hans Scheers, Barthélémy Tandu-Umba, et al.
Clinical Chemistry|September 10, 2011
A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipientsLaure Elens, Rachida Bouamar, Dennis A Hesselink, et al.
Archives of Toxicology|March 29, 2021
Systemic effects and impact on the gut microbiota upon subacute oral exposure to silver acetate in ratsDominique Lison, Jérôme Ambroise, Riccardo Leinardi, et al.
Clinical Biochemistry|January 9, 2016
Quantification of darunavir and etravirine in human peripheral blood mononuclear cells using high performance liquid chromatography tandem mass spectrometry (LC-MS/MS), clinical application in a cohort of 110 HIV-1 infected patients and evidence of a potential drug-drug interactionLeïla Belkhir, Morgane De Laveleye, Bernard Vandercam, et al.
Scientific Reports|July 15, 2024
Effect of ABCB1 most frequent polymorphisms on the accumulation of bictegravir in recombinant HEK293 cell linesJulien De Greef, Mathilde Akue, Nadtha Panin, et al.
Pharmacogenetics and Genomics|September 28, 2011
Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in the Rotterdam StudyLaure Elens, Matthijs L Becker, Vincent Haufroid, et al.
Pageof 16